Optic IconOptic Logo
|
SearchCollectionsBenchmarks
Organization

Adelphi Values

3 abstracts

2 posters

Poster
Mepolizumab Improves Health-Related Quality of Life for Patients With Chronic Rhinosinusitis With Nasal Polyps: Data From the SYNAPSE Study
Poster
Mepolizumab Reduces Disease Symptoms for Patients With Chronic Rhinosinusitis With Nasal Polyps: Data From the SYNAPSE Study
Abstract
Health-related quality of life (HRQoL) and symptoms in LIBRETTO-431 patients with RET fusion-positive advanced non-small-cell lung cancer (NSCLC).
Org: Shanghai Pulmonary Hospital, Shanghai, China, AOU San Luigi, University of Torino, Hospital Ramón y Cajal, University Hospitals KU Leuven,
Abstract
Health-related quality of life (HRQoL) with nivolumab (NIVO) subcutaneous (SC) or intravenous (IV) in patients (pts) with advanced or metastatic clear cell renal cell carcinoma (ccRCC) who have received prior therapy in the phase 3 CheckMate 67T trial.
Org: Roswell Park Comprehensive Cancer Center, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Bristol Myers Squibb, Adelphi Mill, Adelphi Values,
Abstract
Global burden and economic impact of vaccine-preventable cancer mortality.
Org: Center for Observational and Real-World Evidence, MSD Spain, Adelphi Values, Merck Sharp & Dohme, Merck & Co., Inc.,